| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10731024 | Physica Medica | 2016 | 7 Pages |
Abstract
The human factor and the constraints imposed to the target volume have a greater dosimetric impact than treatment planning and radiation delivery technology in stereotactic treatment of liver metastases. Significant differences found both in terms of dosimetric target coverage and OAR sparing should be taken into consideration before starting a multi-institutional SARB clinical trial.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Marco Esposito, Giulia Maggi, Carmelo Marino, Laura Bottalico, Elisabetta Cagni, Claudia Carbonini, Michelina Casale, Stefania Clemente, Valentina D'Alesio, David Fedele, Francesca Romana Giglioli, Valeria Landoni, Anna Martinotti, Roberta Nigro,